1. Home
  2. GBIO vs HQI Comparison

GBIO vs HQI Comparison

Compare GBIO & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • HQI
  • Stock Information
  • Founded
  • GBIO 2016
  • HQI 2002
  • Country
  • GBIO United States
  • HQI United States
  • Employees
  • GBIO N/A
  • HQI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • HQI Professional Services
  • Sector
  • GBIO Health Care
  • HQI Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • HQI Nasdaq
  • Market Cap
  • GBIO 166.2M
  • HQI 172.8M
  • IPO Year
  • GBIO 2020
  • HQI N/A
  • Fundamental
  • Price
  • GBIO $2.59
  • HQI $14.17
  • Analyst Decision
  • GBIO Buy
  • HQI Strong Buy
  • Analyst Count
  • GBIO 4
  • HQI 2
  • Target Price
  • GBIO $7.50
  • HQI $18.00
  • AVG Volume (30 Days)
  • GBIO 74.2K
  • HQI 15.1K
  • Earning Date
  • GBIO 11-07-2024
  • HQI 11-06-2024
  • Dividend Yield
  • GBIO N/A
  • HQI 1.71%
  • EPS Growth
  • GBIO N/A
  • HQI N/A
  • EPS
  • GBIO N/A
  • HQI 0.37
  • Revenue
  • GBIO $13,174,000.00
  • HQI $36,133,000.00
  • Revenue This Year
  • GBIO $99.36
  • HQI N/A
  • Revenue Next Year
  • GBIO N/A
  • HQI $7.62
  • P/E Ratio
  • GBIO N/A
  • HQI $33.48
  • Revenue Growth
  • GBIO 1397.05
  • HQI 3.96
  • 52 Week Low
  • GBIO $0.86
  • HQI $11.39
  • 52 Week High
  • GBIO $4.65
  • HQI $17.31
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 51.42
  • HQI 54.14
  • Support Level
  • GBIO $2.41
  • HQI $13.81
  • Resistance Level
  • GBIO $2.63
  • HQI $14.79
  • Average True Range (ATR)
  • GBIO 0.22
  • HQI 0.52
  • MACD
  • GBIO 0.03
  • HQI -0.01
  • Stochastic Oscillator
  • GBIO 56.79
  • HQI 53.38

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.

Share on Social Networks: